For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate
Modest Impact on Weight While not primarily a weight loss drug, Metformin often leads to modest weight reduction or stabilization, particularly in individuals who are overweight or obese
do not adjust your Wegovy dose yourself
By prompting the pancreas to release insulin at the right times and slowing down stomach emptying, it allows the body to lose weight more easily
The company was ranked #1 by Healthline for overall care in 2021 , 2022 and 2023 , as well as Best for Doctor Choice in 2023 by Forbes and most affordable telehealth in 2023 by CNET